Quantum BioPharma Ltd.
QNTM
$6.30
$0.060.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.36M | -3.83M | -3.11M | -1.90M | -1.39M |
| Total Depreciation and Amortization | 112.80K | 120.80K | 136.80K | 120.10K | 122.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.96M | -372.70K | 44.00K | 366.10K | -297.70K |
| Change in Net Operating Assets | 7.37M | 618.20K | 2.32M | -556.30K | 718.30K |
| Cash from Operations | -835.80K | -3.46M | -606.50K | -1.97M | -851.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.24M | -3.46M | 738.20K | -22.10K | 0.00 |
| Cash from Investing | 1.24M | -3.46M | 738.20K | -22.10K | 0.00 |
| Total Debt Issued | 1.01M | -302.80K | 15.90K | 286.90K | -- |
| Total Debt Repaid | -29.80K | -4.60K | -14.60K | -14.70K | -25.30K |
| Issuance of Common Stock | 1.49M | 7.05M | 1.84M | 296.40K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.47M | 6.74M | 1.84M | 568.70K | -25.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.88M | -186.40K | 1.98M | -1.43M | -876.90K |